Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HEHLMANN, Rüdiger")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 54

  • Page / 3
Export

Selection :

  • and

How I treat CML blast crisisHEHLMANN, Rüdiger.Blood. 2012, Vol 120, Num 4, pp 737-747, issn 0006-4971, 11 p.Article

Chronic myeloid leukaemiaHEHLMANN, Rüdiger; HOCHHAUS, Andreas; BACCARANI, Michele et al.Lancet (British edition). 2007, Vol 370, Num 9584, pp 342-350, issn 0140-6736, 9 p.Article

bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl-2 gene rearrangementsPAPAKONSTANTINOU, Georgios; VERBEKE, Caroline; HASTKA, Jan et al.British journal of haematology. 2001, Vol 113, Num 2, pp 383-390, issn 0007-1048Article

Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-αSCHMIDT, Manuel; HOCHHAUS, Andreas; NITSCHE, Andreas et al.Blood. 2001, Vol 97, Num 11, pp 3648-3650, issn 0006-4971Article

Treatment concepts of acute promyelocytic leukemia : Acute leukemiasLENGFELDER, Eva; SAUSSELE, Susanne; WEISSER, Andreas et al.Critical reviews in oncology/hematology. 2005, Vol 56, Num 2, pp 261-274, issn 1040-8428, 14 p.Article

Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disordersFRANK, Oliver; GIEHL, Michelle; CHUN ZHENG et al.Journal of virology. 2005, Vol 79, Num 17, pp 10890-10901, issn 0022-538X, 12 p.Article

Suitability of the PAXgene™ system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemiaERNST, Thomas; HOFFMANN, Jana; ERBEN, Philipp et al.Clinical chemistry and laboratory medicine. 2008, Vol 46, Num 3, pp 318-322, issn 1434-6621, 5 p.Article

Systemic mastocytosis simulating osseous metastatic diseaseMETZGEROTH, Georgia; DINTER, Dietmar; ERBEN, Philipp et al.British journal of haematology. 2007, Vol 136, Num 1, pp 1-1, issn 0007-1048, 1 p.Article

Assessment of retroviral activity using a universal retrovirus chipSEIFARTH, Wolfgang; SPIESS, Birgit; ZEILFELDER, Udo et al.Journal of virological methods. 2003, Vol 112, Num 1-2, pp 79-91, issn 0166-0934, 13 p.Article

Diagnosis and therapy of polycythemia veraLENGFELDER, Eva; MERX, Kirsten; HEHLMANN, Rüdiger et al.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 3, pp 267-275, issn 0094-6176, 9 p.Article

Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patientHOFHEINZ, Ralf-Dieter; NGUYEN, Xuan-Duc; BUCHHEIDT, Dieter et al.Cancer chemotherapy and pharmacology. 2004, Vol 53, Num 3, pp 276-277, issn 0344-5704, 2 p.Article

Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patientsBUCHHEIDT, Dieter; BAUST, Corinna; SKLADNY, Hevko et al.British journal of haematology. 2002, Vol 116, Num 4, pp 803-811, issn 0007-1048Article

Peritoneal haematopoiesis in acute panmyelosis with myelofibrosisMETZGEROTH, Georgia; REITER, Andreas; BACK, Walter et al.British journal of haematology. 2005, Vol 130, Num 1, issn 0007-1048, p. 1Article

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IVHEHLMANN, Rüdiger; MÜLLER, Martin C; SCHNITTGER, Susanne et al.Journal of clinical oncology. 2014, Vol 32, Num 5, pp 415-423, issn 0732-183X, 9 p.Article

Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNetGUILHOT, Joëlle; BACCARANI, Michele; ROUSSELOT, Philippe et al.Blood. 2012, Vol 119, Num 25, pp 5963-5971, issn 0006-4971, 9 p.Article

Variable Transcriptional Activity of Endogenous Retroviruses in Human Breast CancerFRANK, Oliver; VERBEKE, Caroline; SCHWARZ, Norbert et al.Journal of virology. 2008, Vol 82, Num 4, pp 1808-1818, issn 0022-538X, 11 p.Article

Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patientsSPIESS, Birgit; BUCHHEIDT, Dieter; BAUST, Corinna et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 5, pp 1811-1818, issn 0095-1137, 8 p.Article

Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid LeukemiaBURCHERT, Andreas; MÜLLER, Martin C; KOSTREWA, Philippe et al.Journal of clinical oncology. 2010, Vol 28, Num 8, pp 1429-1435, issn 0732-183X, 7 p.Article

ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemiaERNST, Thomas; HOFFMANN, Jana; ERBEN, Philipp et al.Haematologica (Roma). 2008, Vol 93, Num 9, pp 1389-1393, issn 0390-6078, 5 p.Article

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors : review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing resultsHUGHES, Timothy; DEININGER, Michael; GABERT, Jean et al.Blood. 2006, Vol 108, Num 1, pp 28-37, issn 0006-4971, 10 p.Article

Detection of Aspergillus DNA by a nested PCR assay is superior to blood culture in an experimental murine model of invasive aspergillosisHUMMEL, Margit; BAUST, Corinna; KRETSCHMAR, Marianne et al.Journal of medical microbiology. 2004, Vol 53, Num 8, pp 803-806, issn 0022-2615, 4 p.Article

Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemiaBURCHERT, Andreas; WÖLFL, Stefan; GSCHAIDMEIER, Harald et al.Blood. 2003, Vol 101, Num 1, pp 259-264, issn 0006-4971, 6 p.Article

The European LeukemiaNet: achievements and perspectivesHEHLMANN, Rüdiger; GRIMWADE, David; BÜCHNER, Thomas et al.Haematologica (Roma). 2011, Vol 96, Num 1, pp 156-162, issn 0390-6078, 7 p.Article

Centrosome aberrations and Gi phase arrest after in vitro and in vivo treatment with the SRC/ABL inhibitor dasatinibFABARIUS, Alice; GIEHL, Michelle; REBACZ, Blanka et al.Haematologica (Roma). 2008, Vol 93, Num 8, pp 1145-1154, issn 0390-6078, 10 p.Article

Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemiaKREIL, Sebastian; PFIRRMANN, Markus; HAFERLACH, Claudia et al.Blood. 2007, Vol 110, Num 4, pp 1283-1290, issn 0006-4971, 8 p.Article

  • Page / 3